Found 1648 related files. Current in page 10
Dear Parents, Welcome and thank you for selecting our practice for your child’s dental care. Enclosed with this letter, you will find information that will help us and you prepare for your child’s first office visit. What to Expect: A few words about your child’s first visit…we would like the first visit to be as pleasant as possible. Often, parents and their child do not know what to expect, therefore it is not unusual for both parents and children to be a little apprehensive about the first dental visit. Hopefully, by letting you know how we do things ahead of time; it will make the visit a bit more relaxing. At the initial visit, our goal is to provide a comprehensive exam and diagnosis and to begin preventive dental care with tooth-brushing instructions, teeth cleaning, and fluoride application. As part of the examination, we often take cavity detecting x-rays and occasionally other x-rays to evaluate the health and growth of your child’s teeth. After the examination, your child’s dental health and needs will be discussed with you. Each child is different and we understand this. We will customize your appointment according to your child’s age, needs, and cooperation level. We do not believe in pushing children beyond their ability for treatment.
29-May-09 Page 1 Stair Design Tab: Std Stair Analysis Method: Stair Number: ASD Sample Standard Stair Design Based on 2005 Specification for Structural Steel Buildings Geometry Loads Tread Width L1 : Stringer Spacing L2 : Stringer Length L3 : Landing Width L4 : Landing Pan Support Spacing: 100.00 psf Unif. Load = Handrails = Dead Load = 66.04 plf 50.00 plf 116.04 plf 165.10 plf Total Load = 281.14 plf Concrete = Pans = Misc = 37.50 psf 3.00 psf 4.50 psf 45.00 psf Live Load = Stringers: 25.00 psf 10.00 psf 5.00 psf 40.00 psf Live Load = 2.00 in 3.00 in Concrete = Treads & Pans = Misc = Dead Load = Live Load = Concrete Fill at Treads : Concrete Fill at Landing : Treads: 3.302 ft 6.000 in 10.670 ft 4.135 ft 1.900 ft 100.00 psf Tread Design Tread Gage = I= S= 14 GA 16.60 2.57 Max Imposed Load = Max Tread Capacity = 0.46 k 9.34 k Deflection = 0.016 in Landing: OK = L/2521 Total Load = 145.00 psf Does Wall Stringer have Handrails? No 29-May-09 Page 2 Stair Design Face Stringer max. deflection = Face Stringer Size = Zx = Mark Wt = Ix = S209S1 Channel Fy: Fu: Wall Stringer MC12x14.3 15.24 in3 14.30 plf 76.30 in4 36.00 ksi 58.00 ksi
Journal of Technical Analysis is published by the Market Technicians Association, Inc., (MTA) 61 Broadway, Suite 514, New York, NY 10006. Its purpose is to promote the investigation and analysis of the price and volume activities of the world’s financial markets. Journal of Technical Analysis is distributed to individuals (both academic and practitioner) and libraries in the United States, Canada and several other countries in Europe and Asia. Journal of Technical Analysis is copyrighted by the Market Technicians Association and registered with the Library of Congress. All rights are reserved. 2 Journal of Technical Analysis • 2009 • Issue 66 Letter from the Editor For decades I carried a quote in my wallet from Albert Einstein that goes something like this: As one grows older, one sees the impossibility of imposing one’s will on the chaos with brute force. But if you are patient, there will come that moment in time, when while eating an apple, the solution will present itself politely and say, “Here I am.” We most certainly live in a historic period that many describe as chaotic, but experienced technical analysts around the world reflect in private moments and say “Here we are – again.” The solutions we obtain from our charts come most often in quiet moments only after years of preparation, exhaustive research, and at least a decade of experience. It is this combination that creates an inner calm, allowing solutions to present themselves politely when so many people are in a state of panic and lacking clarity. I believe this issue of the Journal of Technical Analysis will provide insight to many readers about the depth of commitment the authors needed to obtain confidence in the methodologies they employ. This is an exceptional issue showing diversity and depth that will add to our understanding and will serve to guide us all on how best to present our own research summaries. Who will be motivated by this Journal to accept the challenge described at the end of my letter? The MTA Journal of Technical Analysis announced changes in our manuscript review board this year. What does the review board actually do for you? To quote one author whose paper was not accepted, ‘This kind of feedback is invaluable.’ There is more to the review process than you may be aware. While we have an important role to accept papers that reflect the highest standards within our industry, we also strive to further encourage and guide aspiring authors with very detailed comments to further the development of their work.
Technical analysis, also known as “charting,” has been a part of financial practice for many decades, but this discipline has not received the same level of academic scrutiny and acceptance as more traditional approaches such as fundamental analysis. One of the main obstacles is the highly subjective nature of technical analysis—the presence of geometric shapes in historical price charts is often in the eyes of the beholder. In this paper, we propose a systematic and automatic approach to technical pattern recognition using nonparametric kernel regression, and we apply this method to a large number of U.S. stocks from 1962 to 1996 to evaluate the effectiveness of technical analysis. By comparing the unconditional empirical distribution of daily stock returns to the conditional distribution—conditioned on specific technical indicators such as head-and-shoulders or double-bottoms—we find that over the 31-year sample period, several technical indicators do provide incremental information and may have some practical value. ONE OF THE GREATEST GULFS between academic finance and industry practice is the separation that exists between technical analysts and their academic critics. In contrast to fundamental analysis, which was quick to be adopted by the scholars of modern quantitative finance, technical analysis has been an orphan from the very start. It has been argued that the difference between fundamental analysis and technical analysis is not unlike the difference between astronomy and astrology. Among some circles, technical analysis is known as “voodoo finance.” And in his inf luential book A Random Walk down Wall Street, Burton Malkiel ~1996! concludes that “@u#nder scientific scrutiny, chart-reading must share a pedestal with alchemy.” However, several academic studies suggest that despite its jargon and methods, technical analysis may well be an effective means for extracting useful information from market prices. For example, in rejecting the Random Walk * MIT Sloan School of Management and Yale School of Management. Corresponding author: Andrew W. Lo ~firstname.lastname@example.org!. This research was partially supported by the MIT Laboratory for Financial Engineering, Merrill Lynch, and the National Science Foundation ~Grant SBR– 9709976!. We thank Ralph Acampora, Franklin Allen, Susan Berger, Mike Epstein, Narasimhan Jegadeesh, Ed Kao, Doug Sanzone, Jeff Simonoff, Tom Stoker, and seminar participants at the Federal Reserve Bank of New York, NYU, and conference participants at the ColumbiaJAFEE conference, the 1999 Joint Statistical Meetings, RISK 99, the 1999 Annual Meeting of the Society for Computational Economics, and the 2000 Annual Meeting of the American Finance Association for valuable comments and discussion.
Excerpt from: Supplier Management Manual (Chapter 2) As at: 26.11.2009 Version 1.7.5 engl. Handbuch Lieferantenmanagement - extern/intern (vertraulich) - Version 1.7 / 1 2 Basic Requirements for Systems, Processes and Methods Contents Publication: Last Doc. Change: Last QMweb Change: Last Portal Change: external/internal 02.09.2009 20.12.2007 n. a. Basic Requirements for Systems, Processes and Methods 2 2.1 ISO TS 16949 2.2 VDA - Volumes issued by the German Association of the Automotive Industry 2.3 MBST - Mercedes-Benz Special Terms 2.4 Certificate Management 2.5 Electronic Data Interchange 2.6 Data Interchange via XML Interface in acc. to VDA 2.8 SIS - Standards Information System 2.9 Legal Text Online 3 Supplier Management Manual Version 1.7.5 MBC/Q Production Credits File and printed copies of this document are not subject to document change control. The valid version of this document is available from your portal administrator via the Daimler Supplier Portal (https://daimler.portal.covisint.com) 2 2 Basic Requirements for Systems, Processes and Methods Contents 1. Ensuring that organizational principles and objectives are met: 2. Ensuring that the MDS milestones are adhered to: 3. Ensuring that the MPS strategy is followed: 4. Ensuring that QM and vehiclespecific methods are employed: 5. Ensuring that communication is consistent with Extended Enterprise®: Supplier Management Manual Version 1.7.5 MBC/Q Publication: Last Doc. Change: Last QMweb Change: Last Portal Change: external/internal 02.09.2009 20.12.2007 n. a. LOI (= Letter of Intent – in exceptional cases only) Development and production contract Purchase conditions and MBST (Mercedes-Benz Special Terms) Standardized inquiry (including latest possible EMPB) Specifications document (component specifications) Standardized inquiry Drawings, CAD data Daimler-Benz delivery specifications, Mercedes-Benz standards Basic samples for interior materials Basic samples for paintwork Milestone plan in accordance with MDS Mercedes-Benz Special Terms Guideline for product realization, ISO TS 16949 Call-off details (delivery dates, quantities, packaging) Logistics Process Analysis (LPA) All applicable VDA volumes must be taken into account Daimler Process Audit SPICE according to ISO 15504 as per HIS (Manufacturer Initiative Software) Production process and product release as per MBST13 Global Supplier News Journal and Supplier Portal Forums and workshops with suppliers Data interchange via XML interface as per VDA File and printed copies of this document are not subject to document change control. The valid version of this document is available from your portal administrator via the Daimler Supplier Portal (https://daimler.portal.covisint.com)
Hi! Welcome to one of the manuals I have written on retailing, wholesaling and exporting vehicles. Each manual was written to address the issues in each business. There are common issues that cross between the three businesses. . If you have all these manuals you may find that information is repeated in the manuals. They have been for sale for over 10 years. I update them every year so to give you the latest information about the ever changing auto industry. In this manual, I will show you how to break into the wholesale car business. It can offer you a successful career with huge financial rewards. This is not a get rich quick scheme. It is a little known business people are doing every day. The information and guidance given in this book is the product of years of experience. It offers you a simple, but very effective way to make a change to a new career opportunity. It is a high profit business. I reveal all the methods. They're easy to follow. Even if you don't go into the business, you can use this plan to buy your next family car. I guarantee that the things you'll discover in this manual will save you hundreds, if not thousands, on your car purchases! Using wholesale methods, I was able to buy the car of my dreams, a beautiful red Mercedes! I bought it so cheap, the loan officer of the bank wanted to know what was wrong with it! She had to inspect the car before giving final approval on the loan! So let’s get started! First, let me show you why there are huge profits in this business.
European Journal of Medical Research Study Summary November 2009 Sore throat: echinacea-sage spray just as effective as standard medication1 Study objective The first symptom of almost all acute respiratory infections (ARI) is sore throat, which is caused mainly by viral infections of the nasopharynx. Even the most widespread etiological agents of common cold – rhinoviruses – first affect the throat where they cause soreness and only then spread to the nasal region . A considerable proportion of all common cold treatments are therefore formulated to combat and relieve sore throat and the associated inflammation-induced symptoms such as swallowing difficulties. The study described evaluates the effectiveness of acute treatment with a throat spray containing echinacea (Echinacea purpurea) and sage (Salvia officinalis) compared to a standard combination preparation of chlorhexidine and lidocaine in acute painful tonsillitis and/or pharyngitis . Investigators PD Dr. med. Andreas Schapowal, Landquart Allergy Clinic/CH, D. Berger, Schüpfen/CH, Dipl.Math. Peter Klein, Rohrbach/D and Andy Suter, Roggwil/CH and 11 general practitioners. Study design The study was conducted as a multicentre (11 general practices), randomised, double-blind, placebo-controlled trial with a double-dummy design in two parallel groups. The objective was to test the non-inferiority of the echinacea/sage spray compared to the chlorhexidine/lidocaine spray. Study participants After approval by the ethics committees, 154 patients with acute pharyngitis or tonsillitis and sore throat were enrolled in the study. Inclusion criteria: age > 12 years, onset of symptoms < 72h before enrolment and tonsillopharyngitis symptom index ≥ 6. The exclusion criteria related to the use of various medications prior to study enrolment (analgesics < 12h, antibiotics < 24h, mouth and throat therapeutic preparations < 4h, systemic corticosteroids < 1 month). Further reasons for exclusion: bacterial infections or severe systemic diseases, allergies/intolerance to ingredients of the products, as well as pregnancy and breast feeding. Study medications The plant-based active preparation consisted of extracts of Echinacea purpurea (L.) Moench (Echinaforce® concentrate: fresh herb – 95%, roots – 5%) and Salvia officinalis in an extract ratio of 67.8% : 32.2% (A.Vogel Halsschmerz Spray®, A.Vogel AG). The chemically defined reference product contained 1% chlorhexidine gluconate and 2% lido-caine HCl (Collunosol®, Sanofi AG). The placebos used for the double-dummy technique largely corresponded in appearance, taste and aroma to the original products.
The Letter Advocate is a letter-writing service that resolves issues including business disputes and IRS notices by drafting custom correspondences for their clients to utilize for their specific situation. They offer a convenient resource for those who do not have the time or experience to handle these disputes on their own. All letters are custom designed at the direction of the client. For more information visit www.theletteradvocate.com.
10 September 2009_v0.3 LE5860-5862 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Influenza A (H1N1) 2009 Monovalent Vaccine safely and effectively. See full prescribing information for Influenza A (H1N1) 2009 Monovalent Vaccine. -------------------------------CONTRAINDICATIONS-----------Severe hypersensitivity to egg proteins or any component of the vaccine or life-threatening reactions after previous administration of any influenza vaccine. (4, 11) Influenza A (H1N1) 2009 Monovalent Vaccine Manufactured by Sanofi Pasteur Inc. Suspension for Intramuscular Injection Initial US Approval: 1980 -----------------------WARNINGS AND PRECAUTIONS--------------------If Guillain-Barré syndrome (GBS) has occurred within 6 weeks of previous influenza vaccination, the decision to give Influenza A (H1N1) 2009 Monovalent Vaccine should be based on careful consideration of the potential benefits and risks. (5.1) Immunocompromised persons may have a reduced immune response to Influenza A (H1N1) 2009 Monovalent Vaccine. (5.2) ----------------------------RECENT MAJOR CHANGES-----------------------------Indications and Usage ( 1 ) [9/2009] Dosage and Administration ( 2.2 ) [9/2009] ----------------------------INDICATIONS AND USAGE------------------------------Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 6 months of age and older against influenza disease caused by pandemic (H1N1) 2009 virus. (1) --------------------------DOSAGE AND ADMINISTRATION------------------------Based on currently available information the vaccination regimen is as follows: Children ▪ 6 through 35 months of age (0.25 mL dose, intramuscular injection): - Two 0.25 mL doses approximately one month apart. (2.2) ▪ 36 months through 9 years of age (0.5 mL dose, intramuscular injection): - Two 0.5 mL doses approximately one month apart. (2.2) ▪ 10 years of age and older - A single 0.5 mL dose, intramuscular injection. (2.2) Adults - A single 0.5 mL dose, intramuscular injection. (2.2) ---------------------DOSAGE FORMS AND STRENGTHS--------Influenza A (H1N1) 2009 Monovalent Vaccine, a sterile suspension for intramuscular injection, is supplied in four presentations: Prefilled syringe, 0.25 mL, no preservative; distinguished by a pink syringe plunger rod (3) Prefilled syringe, 0.5 mL, no preservative (3) Single-dose vial, 0.5 mL, no preservative (3) Multi-dose vial, 5 mL, contains thimerosal, a mercury derivative, added as a preservative. Each 0.5 mL dose contains 25 mcg mercury. (3, 11 )
THE DESIGN SCHOOL Bachelor of Science in Design: INTERIOR DESIGN Applying To Pass Degree Milestone–Continuing To Second Year For students that have completed (or are currently enrolled in) INT 111, 120, 121, 123, 131, 221, and 222 and have earned a letter grade of “C” or better. Applying to pass the degree milestone requirement is competitive and limited by available spaces. Selection is awarded to those applicants demonstrating the highest promise for professional success. Students who want to apply to other programs must submit separate applications for any of the other programs. Transfers into programs are considered only on a space available basis, and such transfers are limited to students with equivalent course work who are competitive with continuing students (see “Transfer Students and Transfer Work”). Transfer students must be admitted to ASU prior to the application deadline to be eligible to apply online to pass the degree milestone. Students that do not pass the degree milestone should see an academic advisor if they need assistance. Application Deadline and Submission When 5:00 pm, May 2, 2014 Where Portfolio: Submit portfolio and written work to the Design North building, room 162 between regular business hours. (M- F 8:00am – Noon and 1:00pm – 5:00pm) Application: Complete online at https://herbergerinstitute.asu.edu/forms/design/degree_application/ This link will be active starting April 1, 2014. You will receive an e-mail confirmation of your application submission. Make sure your ASU e-mail account is working properly and check it immediately to verify that you received the confirmation. Policy on Late Applications Late applications will not be accepted under any circumstances Qualifications For students that have completed (or are currently enrolled in) INT 111, 120, 121, 123, 131, 221, and 222 with a “C” or better. Selection to pass the degree milestone in Interior Design is limited to applicants who have completed the first-year requirements and who are determined by the admissions committee to have the best potential for academic success. Space in the program is limited. Application materials and Grade Point Average (GPA) will be assessed to determine academic success. Decisions will be made based on the following and weighted with the following percentages: 30% Portfolio, 20% ASU GPA, 25% Interior Design GPA, and 25% Written Statement.